Ionetix Corp / DE /
Last verified 2026-05-07. JSON
| Total raised | $32.0M |
|---|---|
| Latest round | Funding round, $32.0M, 2026-04-09 |
| Founded | unknown |
| Headquarters | LANSING, MI |
| Industry | pharmaceuticals |
| Stage | unknown |
| Website | ionetix.com |
Ionetix develops and supplies radiopharmaceuticals, manufacturing diagnostic PET isotopes and therapeutic radionuclides for cancer imaging and treatment. It serves hospitals doing cardiac PET and oncology therapy plus institutions needing cyclotron solutions. It focuses on scarce isotopes like N-13 ammonia and Actinium-225.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-09 | Funding round | $32.0M | undisclosed |
Detected tech stack
WordPress 6.9.4, Trident AB, Yoast SEO 27.6, Google Analytics, Google Tag Manager, Flywheel 5.1.0, Slider Revolution, jQuery Migrate 3.4.1, PayU Payment, PHP, DoubleClick Floodlight, ContentViews 4.4
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $32.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $32.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | ionetix.com, read 2026-05-07 |
| Description | self-reported | ionetix.com, read 2026-05-07 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $32.0M, 2026-04-09 → Funding round, $32.0M, 2026-04-09, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $32.0M, 2026-04-09 → Funding round, $32.0M, 2026-04-09 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes